NEKTAR THERAPEUTICS (NKTR) Stock Analyst Ratings
NASDAQ:NKTR - Nasdaq - US6402681083 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 79% to NKTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.85. This target is 661.31% above the current price.
NKTR was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about NKTR.
In the previous month the buy percentage consensus was at a similar level.
NKTR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-11 | Jefferies | Upgrade | Hold -> Buy |
| 2025-03-14 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | B. Riley Securities | Initiate | Buy |
| 2024-11-04 | Piper Sandler | Initiate | Overweight |
| 2024-03-06 | Jefferies | Maintains | Hold -> Hold |
| 2023-11-20 | JP Morgan | Reiterate | Underweight |
| 2023-11-09 | TD Cowen | Upgrade | Market Perform -> Outperform |
| 2023-08-07 | Mizuho | Reiterate | Neutral |
| 2023-05-10 | Jefferies | Upgrade | Underperform -> Hold |
| 2023-03-06 | Oppenheimer | Maintains | Perform |
| 2023-02-27 | Goldman Sachs | Maintains | Sell |
| 2023-02-24 | SVB Leerink | Maintains | Market Perform |
| 2023-02-24 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-08-08 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-04-18 | Mizuho | Maintains | Neutral |
| 2022-04-18 | SVB Leerink | Maintains | Market Perform |
| 2022-04-18 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2022-03-09 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-11-08 | Benchmark | Upgrade | Hold -> Buy |
| 2021-11-08 | SVB Leerink | Maintains | Market Perform |
| 2021-11-05 | Oppenheimer | Maintains | Perform |
| 2021-09-10 | B of A Securities | Initiate | Neutral |
| 2021-08-06 | SVB Leerink | Maintains | Market Perform |
| 2021-06-28 | Stifel | Upgrade | Hold -> Buy |
| 2021-05-10 | SVB Leerink | Maintains | Market Perform |
| 2021-04-06 | SVB Leerink | Maintains | Market Perform |
| 2021-02-22 | Benchmark | Downgrade | Buy -> Hold |